Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
02.06.2020
The Three Volcanoes Park LLC  will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay.
More Topics "Three Volcanoes" Park
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
01.04.2020
Previously, in the role of the Senior Vice President, he was in charge of sales, procurement, and innovation at MMC Norilsk Nickel.
More Topics Interros
23.03.2020
The Foundation is now announcing the launch of new large-scale initiatives to help non-profits and their beneficiaries to survive the next few months
More Topics COVID-19 / donations / coronavirus / Vladimir Potanin